Laser Focus World is an industry bedrock—first published in 1965 and still going strong. We publish original articles about cutting-edge advances in lasers, optics, photonics, sensors, and quantum technologies, as well as test and measurement, and the shift currently underway to usher in the photonic integrated circuits, optical interconnects, and copackaged electronics and photonics to deliver the speed and efficiency essential for data centers of the future.

Our 80,000 qualified print subscribers—and 130,000 12-month engaged online audience—trust us to dive in and provide original journalism you won’t find elsewhere covering key emerging areas such as laser-driven inertial confinement fusion, lasers in space, integrated photonics, chipscale lasers, LiDAR, metasurfaces, high-energy laser weaponry, photonic crystals, and quantum computing/sensors/communications. We cover the innovations driving these markets.

Laser Focus World is part of Endeavor Business Media, a division of EndeavorB2B.

Laser Focus World Membership

Never miss any articles, videos, podcasts, or webinars by signing up for membership access to Laser Focus World online. You can manage your preferences all in one place—and provide our editorial team with your valued feedback.

Magazine Subscription

Can you subscribe to receive our print issue for free? Yes, you sure can!

Newsletter Subscription

Laser Focus World newsletter subscription is free to qualified professionals:

The Daily Beam

Showcases the newest content from Laser Focus World, including photonics- and optics-based applications, components, research, and trends. (Daily)

Product Watch

The latest in products within the photonics industry. (9x per year)

Bio & Life Sciences Product Watch

The latest in products within the biophotonics industry. (4x per year)

Laser Processing Product Watch

The latest in products within the laser processing industry. (3x per year)

Get Published!

If you’d like to write an article for us, reach out with a short pitch to Sally Cole Johnson: [email protected]. We love to hear from you.

Photonics Hot List

Laser Focus World produces a video newscast that gives a peek into what’s happening in the world of photonics.

Following the Photons: A Photonics Podcast

Following the Photons: A Photonics Podcast dives deep into the fascinating world of photonics. Our weekly episodes feature interviews and discussions with industry and research experts, providing valuable perspectives on the issues, technologies, and trends shaping the photonics community.

Editorial Advisory Board

  • Professor Andrea M. Armani, University of Southern California
  • Ruti Ben-Shlomi, Ph.D., LightSolver
  • James Butler, Ph.D., Hamamatsu
  • Natalie Fardian-Melamed, Ph.D., Columbia University
  • Justin Sigley, Ph.D., AmeriCOM
  • Professor Birgit Stiller, Max Planck Institute for the Science of Light, and Leibniz University of Hannover
  • Professor Stephen Sweeney, University of Glasgow
  • Mohan Wang, Ph.D., University of Oxford
  • Professor Xuchen Wang, Harbin Engineering University
  • Professor Stefan Witte, Delft University of Technology

Hope for Depression Sufferers: Spravato Delivers Relief in Just Two Hours.

Frisco, TX (Newsworthy.ai) Tuesday Apr 25, 2023 @ 9:00 AM Eastern —

A new depression medication called Spravato, which has recently undergone clinical trials, is showing great promise at providing relief from symptoms of depression in just a few hours. Symptoms associated with depression can include persistent feelings of sadness, lack of interest in activities once enjoyed, and thoughts of suicide.

Spravato offers new hope for those enduring depression symptoms and offers visible results in treating depression symptoms within just a couple of hours, offering hope and relief for people struggling with depression.

Spravato works by targeting glutamate receptors in the brain, restoring balance, and reducing depressive symptoms. This is the first new depression medication to be introduced in over 30 years. As such, it's expected to be a game-changer for millions of depression sufferers who haven't experienced relief with other traditional treatment methods.

Clinical trials have been conducted to test the effectiveness of Spravato, and the results show that participants experienced relief from depression symptoms in as little as two hours after receiving the medication. This is a significant improvement when compared to traditional treatment methods for depression, which can take weeks or even months to take effect.

Prime Psychiatry considers the potential of Spravato to help our patients manage their depression in a way that works quickly and effectively. Currently, they are recommending this medication for those with treatment-resistant depression, as it has shown great promise in those types of patients.

This breakthrough in depression medication offers renewed hope for those who have given up on finding an effective treatment for their symptoms. With this new option available, they can now experience relief from their symptoms in just a few hours, offering the prospect of a better quality of life.

About Prime Psychiatry

Prime Psychiatry is committed to providing individualized care using evidence-based principles. We provide psychiatric evaluations, medication management, Transcranial Magnetic Stimulation (for treatment of depression), Spravato, telepsychiatry, addiction treatment, disability evaluations and individual/couples counseling. Our services are offered to children, adolescents, and adults from 11–65-years. Prime Psychiatry was founded by Dr Efosa Airuehia, who is quadruple board certified in General Psychiatry, Child and Adolescent Psychiatry, Addiction Medicine and Lifestyle Medicine.


This press release is distributed by the Newsworthy.ai™ Press Release Newswire - News Marketing Platform™. Reference URL for this press release is here.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.